Australia Pharmaceuticals & Biotech High Growth Potential Companies

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide.

Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.

Anatara Lifesciences Limited engages in the research and development of non-antibiotic oral solutions for gastro intestinal diseases in animals and humans in Australia.

Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, processing, packaging, and distribution/supply of medicinal cannabis for a range of diseases and medical conditions in Australia.

MGC Pharmaceuticals Limited, a biopharmaceutical company, produces and supplies medicinal cannabis products in Australia, Slovenia, and other European countries.

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in North America and Australia.

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore.

Immutep Limited, a biotechnology company, engages in the research, development, and commercialization of biological products.

Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment.

Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines.

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, the United States, Korea, and internationally.

Palla Pharma Limited produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway.

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally.

Probiotec Limited manufactures, markets, and distributes a range of prescription and over-the-counter pharmaceuticals, complementary medicines, and specialty ingredients in Australia and internationally.

Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas.

Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia.